| > |
Jonathan Moreno, PhD, has been appointed to the National Research Council (NRC) “Committee on Military and Intelligence Methodology for Emergent Physiological and Cognitive/Neural Science Research in the Next Two Decades.” |
| > |
The committee will develop approaches to identification of trends in physiological and cognitive/neural science research that may help the U.S. Intelligence Community anticipate the state of such research internationally in the year 2027. |
| > |
Dr. Moreno, who is Professor of Medical Ethics at the University of Pennsylvania School of Medicine, the David and Lyn Silfen University Professor, and Professor of the History and Sociology of Science at the Penn, was nominated for his expertise in neuroethics and bioethics. |
(PHILADELPHIA) – Jonathan Moreno, PhD, has been appointed to the National Research Council (NRC) “Committee on Military and Intelligence Methodology for Emergent Physiological and Cognitive/Neural Science Research in the Next Two Decades.” Dr. Moreno, who is Professor of Medical Ethics at the University of Pennsylvania School of Medicine, the David and Lyn Silfen University Professor, and Professor of the History and Sociology of Science at the Penn, was nominated for his expertise in neuroethics and bioethics.
According to the NRC, the committee will develop approaches to identification of trends in physiological and cognitive/neural science research that may help the U.S. Intelligence Community anticipate the state of such research internationally in the year 2027 and, especially, to help prepare for possible implications affecting future U.S. warfighting capabilities.
Dr. Moreno is an elected member of the Institute of Medicine of the National Academies, where he has served on numerous boards and committees. He is also a Senior Fellow at the Center for American Progress in Washington, D.C. and a Visiting Professor of Biomedical Ethics at the University of Virginia. From 1998 to 2006, Dr. Moreno held the Emily Davie and Joseph S. Kornfeld Chair in Biomedical Ethics at the University of Virginia. He co-chaired the Committee on Guidelines for Human Embryonic Stem Cell Research, has served as a senior staff member for two presidential advisory committees, and has given invited testimony for both houses of Congress. Dr. Moreno has published more than 250 papers, reviews and book chapters, and is a member of several editorial boards. Dr. Moreno’s most recent book is Mind Wars: Brain Research and National Defense (Dana Press, 2006). He is a frequent guest on news and information programs and is often cited and quoted in major national publications.
###
PENN Medicine is a $2.9 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S. News
& World Report's most recent ranking of top research-oriented
medical schools. Supporting 1,400 fulltime faculty and 700 students,
the School of Medicine is recognized worldwide for its superior
education and training of the next generation of physician-scientists
and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals,
all of which have received numerous national patient-care honors [Hospital
of the University of Pennsylvania; Pennsylvania Hospital, the nation's
first hospital; and Penn Presbyterian Medical Center]; a faculty practice
plan; a primary-care provider network; two multispecialty satellite
facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.